Who: Raza Bokhari came to Philadelphia from Pakistan nearly three decades ago after he earned his doctor of medicine degree from the University of Punjab, Rawalpindi Medical College. A brief tenure at a start-up clinical lab in North Philadelphia drove his desire to step away from his surgery scalpel and delve deeper into the entrepreneurial side of […]

FSD Pharma Inc (CSE:HUGE) (OTCMKTS:FSDDF) is beefing up its board of directors, the company announced Wednesday. James Datin, CEO of the bioanalytics lab BioAgilytix, and Robert Ciaruffoli, the co-founder and vice chairman of the 100-member angel investor network Broad Street Angels, are joining the board.

As the prescription cannabinoid market heats up, FSD Pharma has tapped some expert help—in the form of a new CEO who previously headed up marketing for rival GW Pharmaceuticals.